PEGFILGRASTIM

PEGFILGRASTIM was reported 11978 times

These side effects are most commonly reported by patients taking PEGFILGRASTIM:

# Side effect Count
0 DEVICE ADHESION ISSUE 11933
1 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10265
2 UNINTENTIONAL MEDICAL DEVICE REMOVAL 8999
3 DEVICE MALFUNCTION 6943
4 DEVICE USE ERROR 6057
5 DEVICE ISSUE 5176
6 ACCIDENTAL EXPOSURE TO PRODUCT 5007
7 FEBRILE NEUTROPENIA 3819
8 OFF LABEL USE 3796
9 DEVICE OCCLUSION 3368
10 BONE PAIN 2947
11 DEATH 2804
12 NEUTROPENIA 2689
13 FATIGUE 2673
14 PYREXIA 2519
15 NAUSEA 2499
16 DRUG DOSE OMISSION BY DEVICE 2121
17 DRUG DOSE OMISSION 2104
18 DIARRHOEA 2008
19 PAIN 1777
20 ALOPECIA 1738
21 DYSPNOEA 1633
22 INTERCEPTED PRODUCT PREPARATION ERROR 1575
23 ANAEMIA 1443
24 VOMITING 1438
25 OCCUPATIONAL EXPOSURE TO PRODUCT 1413
26 DEVICE LEAKAGE 1404
27 APPLICATION SITE HAEMORRHAGE 1397
28 DEVICE PHYSICAL PROPERTY ISSUE 1394
29 WHITE BLOOD CELL COUNT DECREASED 1284
30 APPLICATION SITE PAIN 1273
31 ASTHENIA 1208
32 THROMBOCYTOPENIA 1138
33 HYPERHIDROSIS 1128
34 PNEUMONIA 1100
35 ARTHRALGIA 1070
36 UNDERDOSE 1054
37 BACK PAIN 1041
38 DRUG INEFFECTIVE 1018
39 MALAISE 1009
40 HEADACHE 961
41 DECREASED APPETITE 905
42 NEUROPATHY PERIPHERAL 904
43 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 884
44 PRODUCT STORAGE ERROR 862
45 NEUTROPHIL COUNT DECREASED 856
46 PAIN IN EXTREMITY 847
47 HOSPITALISATION 842
48 CONSTIPATION 838
49 DEVICE FAILURE 838
50 RASH 790
51 SEPSIS 763
52 DEHYDRATION 725
53 DIZZINESS 713
54 COUGH 703
55 MYALGIA 690
56 PLATELET COUNT DECREASED 688
57 ABDOMINAL PAIN 684
58 INFECTION 647
59 CHEST PAIN 625
60 HYPOTENSION 612
61 LEUKOPENIA 576
62 PANCYTOPENIA 575
63 GENERAL PHYSICAL HEALTH DETERIORATION 573
64 WEIGHT DECREASED 569
65 DISEASE PROGRESSION 563
66 PRODUCT PREPARATION ERROR 558
67 URINARY TRACT INFECTION 518
68 ANXIETY 517
69 NEEDLE ISSUE 513
70 INCORRECT DOSE ADMINISTERED BY DEVICE 509
71 FALL 502
72 HAEMOGLOBIN DECREASED 488
73 DEVICE POWER SOURCE ISSUE 486
74 FEELING ABNORMAL 476
75 PRODUCT DOSE OMISSION 465
76 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 461
77 WHITE BLOOD CELL COUNT INCREASED 452
78 INSOMNIA 447
79 MUCOSAL INFLAMMATION 440
80 INCORRECT DOSE ADMINISTERED 423
81 APPLICATION SITE DISCOMFORT 420
82 UNEVALUABLE EVENT 412
83 DEVICE ELECTRICAL FINDING 409
84 HAIR TEXTURE ABNORMAL 404
85 HAIR COLOUR CHANGES 401
86 PSYCHOLOGICAL TRAUMA 400
87 PULMONARY EMBOLISM 397
88 INVESTIGATION 392
89 INJECTION SITE PAIN 383
90 PARAESTHESIA 382
91 ERYTHEMA 379
92 STOMATITIS 372
93 MADAROSIS 367
94 DEVICE DELIVERY SYSTEM ISSUE 366
95 HYPERSENSITIVITY 365
96 ABDOMINAL PAIN UPPER 364
97 INCORRECT DISPOSAL OF PRODUCT 359
98 PRURITUS 359
99 SYNCOPE 357
100 INTERCEPTED PRODUCT ADMINISTRATION ERROR 356
101 PRODUCT COMMUNICATION ISSUE 352
102 LEUKOCYTOSIS 343
103 CHILLS 342
104 OEDEMA PERIPHERAL 342
105 ACUTE KIDNEY INJURY 341
106 HYPOKALAEMIA 340
107 RESPIRATORY FAILURE 340
108 HYPOAESTHESIA 336
109 CONFUSIONAL STATE 321
110 HAIR DISORDER 318
111 OROPHARYNGEAL PAIN 317
112 PLEURAL EFFUSION 313
113 WHITE BLOOD CELL COUNT ABNORMAL 307
114 MUSCULOSKELETAL PAIN 305
115 TACHYCARDIA 305
116 SEPTIC SHOCK 295
117 MALIGNANT NEOPLASM PROGRESSION 287
118 MUSCLE SPASMS 287
119 ATRIAL FIBRILLATION 281
120 APPLICATION SITE BRUISE 277
121 NEUTROPHIL COUNT ABNORMAL 277
122 DYSGEUSIA 275
123 EPISTAXIS 271
124 ADVERSE EVENT 268
125 PRODUCT USE IN UNAPPROVED INDICATION 266
126 CHEST DISCOMFORT 263
127 NEUTROPENIC SEPSIS 258
128 GAIT DISTURBANCE 257
129 EMOTIONAL DISTRESS 256
130 URTICARIA 252
131 DYSPHAGIA 250
132 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 248
133 THROMBOSIS 248
134 HYPERTENSION 247
135 LYMPHADENOPATHY 246
136 PNEUMONITIS 246
137 DEEP VEIN THROMBOSIS 233
138 GASTROINTESTINAL DISORDER 226
139 HYPOXIA 226
140 C-REACTIVE PROTEIN INCREASED 224
141 INTERSTITIAL LUNG DISEASE 224
142 HYPONATRAEMIA 222
143 SOMNOLENCE 222
144 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 217
145 DEVICE ALARM ISSUE 214
146 CONDITION AGGRAVATED 211
147 RENAL FAILURE 210
148 ORAL PAIN 208
149 LOSS OF CONSCIOUSNESS 206
150 MUSCULAR WEAKNESS 206
151 FLUSHING 204
152 CELLULITIS 203
153 INFLUENZA LIKE ILLNESS 202
154 DEVICE PLACEMENT ISSUE 201
155 DRUG HYPERSENSITIVITY 196
156 COLITIS 195
157 DYSPEPSIA 195
158 ABDOMINAL DISCOMFORT 193
159 ADVERSE DRUG REACTION 192
160 HEART RATE INCREASED 192
161 ATELECTASIS 188
162 DRUG DELIVERY SYSTEM MALFUNCTION 187
163 MOBILITY DECREASED 187
164 HOT FLUSH 181
165 PRODUCTIVE COUGH 181
166 PERIPHERAL SWELLING 178
167 TREMOR 178
168 ALANINE AMINOTRANSFERASE INCREASED 177
169 DEPRESSION 177
170 DEVICE DEPLOYMENT ISSUE 177
171 DRY SKIN 177
172 PALPITATIONS 176
173 ABDOMINAL DISTENSION 175
174 ASPARTATE AMINOTRANSFERASE INCREASED 175
175 NASOPHARYNGITIS 173
176 COVID-19 165
177 HYPERGLYCAEMIA 165
178 ANAPHYLACTIC REACTION 164
179 DYSPNOEA EXERTIONAL 163
180 INJECTION SITE HAEMORRHAGE 162
181 NECK PAIN 162
182 BLOOD CREATININE INCREASED 161
183 DEVICE DISLOCATION 161
184 MEMORY IMPAIRMENT 160
185 BLOOD PRESSURE DECREASED 158
186 IMPAIRED QUALITY OF LIFE 157
187 TOXICITY TO VARIOUS AGENTS 156
188 OEDEMA 153
189 BODY TEMPERATURE INCREASED 152
190 APPLICATION SITE ERYTHEMA 150
191 BLOOD ALKALINE PHOSPHATASE INCREASED 146
192 NEOPLASM PROGRESSION 145
193 RHINORRHOEA 145
194 BLOOD COUNT ABNORMAL 144
195 DISCOMFORT 144
196 ASCITES 143
197 NEUTROPHIL COUNT INCREASED 143
198 NIGHT SWEATS 141
199 ORAL CANDIDIASIS 141
200 RED BLOOD CELL COUNT DECREASED 141
201 SLEEP DISORDER 141
202 BONE MARROW FAILURE 140
203 ACUTE RESPIRATORY DISTRESS SYNDROME 138
204 LUNG DISORDER 138
205 AORTITIS 137
206 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 137
207 ARRHYTHMIA 136
208 CARDIAC FAILURE 136
209 COGNITIVE DISORDER 135
210 CONTUSION 134
211 FEELING HOT 134
212 LYMPHOPENIA 134
213 INFLAMMATION 133
214 OVERDOSE 133
215 SWELLING FACE 133
216 METASTASES TO CENTRAL NERVOUS SYSTEM 132
217 DRUG INTERACTION 131
218 HYPOPHAGIA 131
219 NEOPLASM MALIGNANT 130
220 LACRIMATION INCREASED 129
221 LOWER RESPIRATORY TRACT INFECTION 129
222 EJECTION FRACTION DECREASED 128
223 MYOCARDIAL INFARCTION 128
224 WEIGHT INCREASED 128
225 CYTOKINE RELEASE SYNDROME 127
226 STAPHYLOCOCCAL BACTERAEMIA 127
227 HAEMATOCRIT DECREASED 126
228 PRODUCT DOSE OMISSION ISSUE 126
229 INFLUENZA 125
230 PRODUCT USE ISSUE 125
231 CANDIDA INFECTION 124
232 LETHARGY 124
233 RENAL FAILURE ACUTE 124
234 VISION BLURRED 124
235 FEBRILE BONE MARROW APLASIA 123
236 INFUSION RELATED REACTION 123
237 PAIN IN JAW 123
238 VISUAL IMPAIRMENT 123
239 JOINT SWELLING 122
240 THERAPEUTIC RESPONSE DECREASED 122
241 DEVICE DIFFICULT TO USE 121
242 LABORATORY TEST ABNORMAL 121
243 MYELOSUPPRESSION 121
244 BRONCHITIS 117
245 GASTROINTESTINAL HAEMORRHAGE 116
246 BLOOD LACTATE DEHYDROGENASE INCREASED 115
247 SKIN EXFOLIATION 115
248 CHEMOTHERAPY 112
249 MULTIPLE ORGAN DYSFUNCTION SYNDROME 111
250 DEVICE DEFECTIVE 110
251 PERIPHERAL SENSORY NEUROPATHY 110
252 CLOSTRIDIUM DIFFICILE INFECTION 108
253 SPINAL PAIN 108
254 UPPER RESPIRATORY TRACT INFECTION 108
255 GAMMA-GLUTAMYLTRANSFERASE INCREASED 107
256 HERPES ZOSTER 107
257 DYSURIA 106
258 SWELLING 106
259 VASCULITIS 106
260 DYSPHONIA 105
261 HYPOTHYROIDISM 105
262 MUSCULOSKELETAL CHEST PAIN 105
263 MYELODYSPLASTIC SYNDROME 105
264 GASTROOESOPHAGEAL REFLUX DISEASE 104
265 METASTASES TO LIVER 103
266 SPLENOMEGALY 103
267 DRY MOUTH 102
268 SINUSITIS 102
269 MOUTH ULCERATION 101
270 CARDIAC ARREST 100
271 INTERCEPTED MEDICATION ERROR 100
272 PULMONARY TOXICITY 100
273 RESTLESSNESS 100
274 CEREBROVASCULAR ACCIDENT 99
275 HYPOACUSIS 99
276 OXYGEN SATURATION DECREASED 99
277 BLOOD MAGNESIUM DECREASED 98
278 BLOOD POTASSIUM DECREASED 98
279 STAPHYLOCOCCAL INFECTION 98
280 BALANCE DISORDER 96
281 BLOOD GLUCOSE INCREASED 96
282 METASTASES TO BONE 96
283 CARDIAC DISORDER 95
284 HYPOMAGNESAEMIA 95
285 ACUTE MYELOID LEUKAEMIA 94
286 BACTERAEMIA 94
287 CARDIAC FAILURE CONGESTIVE 94
288 LYMPHOCYTE COUNT DECREASED 94
289 MENTAL STATUS CHANGES 94
290 SURGERY 94
291 HAEMORRHAGE 93
292 RASH MACULO-PAPULAR 93
293 INJURY ASSOCIATED WITH DEVICE 92
294 PNEUMOCYSTIS JIROVECII PNEUMONIA 92
295 BLOOD PRESSURE INCREASED 90
296 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 90
297 DRUG INTOLERANCE 90
298 LUNG INFILTRATION 90
299 CYSTITIS 89
300 DEVICE RELATED INFECTION 89
301 MUSCLE TWITCHING 89
302 HAEMATOTOXICITY 88
303 RENAL IMPAIRMENT 88
304 VIRAL INFECTION 88
305 LIMB DISCOMFORT 87
306 SKIN DISCOLOURATION 87
307 AGRANULOCYTOSIS 86
308 INTENTIONAL PRODUCT MISUSE 86
309 POLYNEUROPATHY 86
310 RESPIRATORY DISTRESS 85
311 ILL-DEFINED DISORDER 84
312 LYMPHOMA 84
313 SEIZURE 84
314 NEURALGIA 83
315 BREAST CANCER 82
316 GASTRITIS 82
317 RASH PRURITIC 82
318 SPEECH DISORDER 82
319 THERAPY NON-RESPONDER 82
320 TRANSFUSION 81
321 HEPATIC ENZYME INCREASED 80
322 LEFT VENTRICULAR DYSFUNCTION 80
323 BLOOD BILIRUBIN INCREASED 79
324 BREAST CANCER METASTATIC 79
325 EMBOLISM 79
326 HYPOCALCAEMIA 79
327 LYMPHOEDEMA 79
328 MUSCULOSKELETAL STIFFNESS 79
329 CLOSTRIDIUM DIFFICILE COLITIS 78
330 NEUTROPENIC COLITIS 78
331 HAEMATOCHEZIA 77
332 HAEMATOMA 76
333 METASTASES TO LYMPH NODES 76
334 NERVOUSNESS 76
335 COLONY STIMULATING FACTOR THERAPY 75
336 COMPUTERISED TOMOGRAM THORAX ABNORMAL 74
337 FULL BLOOD COUNT DECREASED 74
338 HAEMORRHOIDS 74
339 PULMONARY FIBROSIS 74
340 PULMONARY OEDEMA 74
341 MEDICATION ERROR 73
342 POLLAKIURIA 73
343 OSTEONECROSIS OF JAW 72
344 REFUSAL OF TREATMENT BY PATIENT 72
345 THERAPY PARTIAL RESPONDER 72
346 BURNING SENSATION 71
347 MAGNETIC RESONANCE IMAGING 71
348 MIGRAINE 71
349 WHEEZING 71
350 DEVICE BATTERY ISSUE 70
351 FLUID RETENTION 69
352 NAIL DISORDER 69
353 RASH ERYTHEMATOUS 69
354 BLOOD SODIUM DECREASED 68
355 CIRCULATORY COLLAPSE 68
356 NO ADVERSE EVENT 68
357 PLASMA CELL MYELOMA 68
358 RECTAL HAEMORRHAGE 68
359 SINUS TACHYCARDIA 68
360 ALOPECIA AREATA 67
361 DEVICE MECHANICAL ISSUE 67
362 DIFFUSE LARGE B-CELL LYMPHOMA 67
363 ENCEPHALOPATHY 67
364 HAEMOPTYSIS 67
365 LUNG NEOPLASM MALIGNANT 67
366 TENDERNESS 67
367 WHITE BLOOD CELL DISORDER 67
368 ARTHRITIS 66
369 HEART RATE ABNORMAL 66
370 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 66
371 ECZEMA 65
372 ILLNESS 65
373 INJURY 65
374 LUNG INFECTION 65
375 NASAL CONGESTION 65
376 OESOPHAGITIS 65
377 PNEUMONIA ASPIRATION 65
378 ACUTE RESPIRATORY FAILURE 64
379 HAEMATURIA 64
380 METASTASES TO LUNG 64
381 MUSCULOSKELETAL DISCOMFORT 64
382 RASH GENERALISED 64
383 DELIRIUM 63
384 DIVERTICULITIS 63
385 EXTRA DOSE ADMINISTERED 63
386 HYPOALBUMINAEMIA 63
387 THROAT TIGHTNESS 63
388 URINARY INCONTINENCE 63
389 WOUND 63
390 APPLICATION SITE SWELLING 62
391 EAR PAIN 62
392 PALLOR 62
393 SKIN LESION 62
394 APPLICATION SITE DISCOLOURATION 61
395 BACTERIAL INFECTION 61
396 GASTROENTERITIS 61
397 SKIN DISORDER 61
398 TUMOUR LYSIS SYNDROME 61
399 DEPRESSED MOOD 60
400 ESCHERICHIA INFECTION 60
401 NON-HODGKIN^S LYMPHOMA 60
402 SWOLLEN TONGUE 60
403 ANAPHYLACTIC SHOCK 59
404 ASTHMA 59
405 FEELING COLD 59
406 FLATULENCE 59
407 GLOSSODYNIA 59
408 RESPIRATORY TRACT INFECTION 59
409 VASCULAR DEVICE INFECTION 59
410 BLISTER 58
411 BONE DISORDER 58
412 HEPATIC FAILURE 58
413 INJECTION SITE ERYTHEMA 58
414 PELVIC PAIN 58
415 PNEUMOTHORAX 58
416 INGUINAL HERNIA 57
417 TINNITUS 57
418 TOOTHACHE 57
419 CYTOPENIA 56
420 HODGKIN^S DISEASE 56
421 INTESTINAL OBSTRUCTION 56
422 NEUTROPENIC INFECTION 56
423 PULMONARY CONGESTION 56
424 CEREBRAL INFARCTION 55
425 HEPATIC STEATOSIS 55
426 ILEUS 55
427 KLEBSIELLA INFECTION 55
428 LIP SWELLING 55
429 NUCLEAR MAGNETIC RESONANCE IMAGING 55
430 ABDOMINAL TENDERNESS 54
431 ACUTE MYOCARDIAL INFARCTION 54
432 BLOOD TEST ABNORMAL 54
433 FUNGAL INFECTION 54
434 HYPERKALAEMIA 54
435 VERTIGO 54
436 HYPOKINESIA 53
437 LOCAL SWELLING 53
438 LYMPHADENITIS 53
439 SPLENIC RUPTURE 53
440 CONVULSION 52
441 DISORIENTATION 52
442 DRUG EFFECT INCOMPLETE 52
443 DRY EYE 52
444 INJECTION SITE BRUISING 52
445 INJECTION SITE REACTION 52
446 LIVER FUNCTION TEST ABNORMAL 52
447 MULTI-ORGAN FAILURE 52
448 PAIN OF SKIN 52
449 PRESYNCOPE 52
450 PROTEINURIA 52
451 PSEUDOMONAL SEPSIS 52
452 PSEUDOMONAS INFECTION 52
453 AGEUSIA 51
454 APPLICATION SITE PRURITUS 51
455 PERICARDIAL EFFUSION 51
456 STAPHYLOCOCCAL SEPSIS 51
457 APPLICATION SITE IRRITATION 50
458 DIABETES MELLITUS 50
459 HEPATIC FUNCTION ABNORMAL 50
460 LIVER DISORDER 50
461 NO THERAPEUTIC RESPONSE 50
462 OBESITY 50
463 ODYNOPHAGIA 50
464 ORAL HERPES 50
465 PARAESTHESIA ORAL 50
466 SKIN INFECTION 50
467 TACHYPNOEA 50
468 ARTERITIS 49
469 CYSTITIS HAEMORRHAGIC 49
470 DEAFNESS 49
471 IMPAIRED HEALING 49
472 INTERVERTEBRAL DISC PROTRUSION 49
473 PHLEBITIS 49
474 PULMONARY MASS 49
475 CARDIO-RESPIRATORY ARREST 48
476 EATING DISORDER 48
477 ELECTROLYTE IMBALANCE 48
478 HYPERCALCAEMIA 48
479 INTESTINAL PERFORATION 48
480 OCULAR HYPERAEMIA 48
481 OSTEOMYELITIS 48
482 PHARYNGEAL OEDEMA 48
483 RENAL CYST 48
484 SMALL INTESTINAL OBSTRUCTION 48
485 ANGIOEDEMA 47
486 BRAIN OEDEMA 47
487 DYSSTASIA 47
488 HYPERBILIRUBINAEMIA 47
489 INCORRECT ROUTE OF DRUG ADMINISTRATION 47
490 INTENTIONAL PRODUCT USE ISSUE 47
491 MENTAL DISORDER 47
492 NERVOUS SYSTEM DISORDER 47
493 RADIOTHERAPY 47
494 RESPIRATORY DISORDER 47
495 SKIN ULCER 47
496 SLEEP APNOEA SYNDROME 47
497 STRESS 47
498 SYSTEMIC INFECTION 47
499 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47
500 AGITATION 46
501 CEREBRAL HAEMORRHAGE 46
502 MYOCARDITIS 46
503 NEUROTOXICITY 46
504 RASH MACULAR 46
505 RESPIRATORY SYNCYTIAL VIRUS INFECTION 46
506 SENSORY DISTURBANCE 46
507 BLOOD CALCIUM DECREASED 45
508 BLOOD CREATINE INCREASED 45
509 DISEASE RECURRENCE 45
510 HICCUPS 45
511 MUSCULOSKELETAL DISORDER 45
512 PANCREATITIS 45
513 PLATELET COUNT ABNORMAL 45
514 ADVERSE REACTION 44
515 FEEDING DISORDER 44
516 HEPATOTOXICITY 44
517 INCORRECT PRODUCT STORAGE 44
518 INJECTION SITE DISCOMFORT 44
519 SKIN FISSURES 44
520 TASTE DISORDER 44
521 CARDIOMYOPATHY 43
522 CHRONIC LYMPHOCYTIC LEUKAEMIA 43
523 FACE OEDEMA 43
524 FOETAL EXPOSURE DURING PREGNANCY 43
525 OSTEONECROSIS 43
526 OSTEOPOROSIS 43
527 POOR QUALITY DEVICE USED 43
528 SHOCK 43
529 TRANSAMINASES INCREASED 43
530 TRIPLE NEGATIVE BREAST CANCER 43
531 WRONG DRUG ADMINISTERED 43
532 AMNESIA 42
533 CAPILLARY LEAK SYNDROME 42
534 CYTOMEGALOVIRUS INFECTION 42
535 DERMATITIS ACNEIFORM 42
536 EYE DISORDER 42
537 FEBRILE INFECTION 42
538 HAEMOGLOBIN ABNORMAL 42
539 HAEMORRHAGE INTRACRANIAL 42
540 PLATELET COUNT INCREASED 42
541 SPUTUM DISCOLOURED 42
542 URINARY RETENTION 42
543 BLOOD CULTURE POSITIVE 41
544 BLOOD DISORDER 41
545 ENTERITIS 41
546 HYDRONEPHROSIS 41
547 HYPERPYREXIA 41
548 HYPOGLYCAEMIA 41
549 HYPOPHOSPHATAEMIA 41
550 POOR QUALITY SLEEP 41
551 UROSEPSIS 41
552 APLASIA 40
553 APPLICATION SITE EXTRAVASATION 40
554 HALLUCINATION 40
555 PETECHIAE 40
556 RENAL DISORDER 40
557 SKIN REACTION 40
558 TRANSITIONAL CELL CARCINOMA 40
559 ABDOMINAL PAIN LOWER 39
560 BREAST CANCER RECURRENT 39
561 COMPUTERISED TOMOGRAM THORAX 39
562 DISSEMINATED INTRAVASCULAR COAGULATION 39
563 INTERVERTEBRAL DISC DISORDER 39
564 MONOPLEGIA 39
565 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 39
566 SUPRAVENTRICULAR TACHYCARDIA 39
567 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 38
568 CENTRAL VENOUS CATHETERISATION 38
569 EYE PAIN 38
570 HYPERTHERMIA 38
571 NEUTROPHILIA 38
572 SPINAL FRACTURE 38
573 UTERINE ENLARGEMENT 38
574 VARICOSE VEIN 38
575 VENOOCCLUSIVE LIVER DISEASE 38
576 APPLICATION SITE REACTION 37
577 BODY TEMPERATURE ABNORMAL 37
578 COMPUTERISED TOMOGRAM 37
579 DERMATITIS 37
580 DERMATITIS CONTACT 37
581 DYSARTHRIA 37
582 EPILEPSY 37
583 GINGIVAL PAIN 37
584 HYPERVENTILATION 37
585 METABOLIC ACIDOSIS 37
586 NON-CARDIAC CHEST PAIN 37
587 SCAR 37
588 THROAT IRRITATION 37
589 TISSUE INFILTRATION 37
590 ULCER 37
591 ANGINA PECTORIS 36
592 BLOOD UREA INCREASED 36
593 DEVICE MONITORING PROCEDURE NOT PERFORMED 36
594 EYE SWELLING 36
595 LOCALISED INFECTION 36
596 MALNUTRITION 36
597 MASS 36
598 OSTEOARTHRITIS 36
599 RECURRENT CANCER 36
600 STREPTOCOCCAL SEPSIS 36
601 TERMINAL STATE 36
602 TOOTH INFECTION 36
603 VISUAL ACUITY REDUCED 36
604 ACTIVITIES OF DAILY LIVING IMPAIRED 35
605 ANOREXIA 35
606 APPLICATION SITE MASS 35
607 DEMENTIA 35
608 DEPRESSED LEVEL OF CONSCIOUSNESS 35
609 DRUG ABUSE 35
610 EMOTIONAL DISORDER 35
611 ENTEROCOLITIS 35
612 FLANK PAIN 35
613 GASTRIC ULCER 35
614 HYPERAESTHESIA 35
615 MASTECTOMY 35
616 NEPHROLITHIASIS 35
617 PARONYCHIA 35
618 SUDDEN DEATH 35
619 VAGINAL HAEMORRHAGE 35
620 BASAL GANGLION DEGENERATION 34
621 BRADYCARDIA 34
622 CLOSTRIDIAL INFECTION 34
623 DERMATITIS ALLERGIC 34
624 HOSPICE CARE 34
625 HYPERSOMNIA 34
626 LIMB INJURY 34
627 RED CELL DISTRIBUTION WIDTH INCREASED 34
628 SPINAL OSTEOARTHRITIS 34
629 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 34
630 TONGUE ULCERATION 34
631 TOOTH ABSCESS 34
632 UPPER GASTROINTESTINAL HAEMORRHAGE 34
633 ABASIA 33
634 ABSCESS 33
635 BEDRIDDEN 33
636 BONE LESION 33
637 BONE MARROW DISORDER 33
638 CHOLELITHIASIS 33
639 DECUBITUS ULCER 33
640 DEVICE MATERIAL ISSUE 33
641 DYSAESTHESIA 33
642 FEAR 33
643 GENERALISED OEDEMA 33
644 HEMIPARESIS 33
645 MICTURITION URGENCY 33
646 PANCREATIC CARCINOMA 33
647 PERITONITIS 33
648 PREMATURE BABY 33
649 PRODUCT ADMINISTRATION ERROR 33
650 PRODUCT PACKAGING ISSUE 33
651 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33
652 RETCHING 33
653 SENSORY LOSS 33
654 THROMBOPHLEBITIS 33
655 ADRENAL INSUFFICIENCY 32
656 BLOOD URINE PRESENT 32
657 BRAIN FOG 32
658 CHOLECYSTITIS 32
659 HEAD INJURY 32
660 HYPOCHROMIC ANAEMIA 32
661 IRON DEFICIENCY ANAEMIA 32
662 NEUROLOGICAL DECOMPENSATION 32
663 ORAL DISORDER 32
664 RASH PAPULAR 32
665 RHABDOMYOLYSIS 32
666 THERAPY INTERRUPTED 32
667 THROMBOCYTOSIS 32
668 APHASIA 31
669 BREAST PAIN 31
670 CARDIOTOXICITY 31
671 DEVICE USE ISSUE 31
672 GAIT INABILITY 31
673 GASTRIC DISORDER 31
674 INJECTION SITE SWELLING 31
675 JOINT STIFFNESS 31
676 LYMPH NODE PAIN 31
677 MELAENA 31
678 MITRAL VALVE INCOMPETENCE 31
679 MUSCLE SPASTICITY 31
680 PSYCHOGENIC SEIZURE 31
681 STREPTOCOCCAL INFECTION 31
682 TOXIC SKIN ERUPTION 31
683 TRICUSPID VALVE INCOMPETENCE 31
684 BLOOD ALBUMIN DECREASED 30
685 CACHEXIA 30
686 CHROMATURIA 30
687 FACIAL PAIN 30
688 GASTROINTESTINAL TOXICITY 30
689 LIVER FUNCTION TEST INCREASED 30
690 NAIL DISCOLOURATION 30
691 APPLICATION SITE RASH 29
692 FLUID INTAKE REDUCED 29
693 LARGE INTESTINE PERFORATION 29
694 MONOCYTE COUNT INCREASED 29
695 PULMONARY THROMBOSIS 29
696 SUBCLAVIAN VEIN THROMBOSIS 29
697 SYRINGE ISSUE 29
698 TONGUE DISORDER 29
699 APHTHOUS ULCER 28
700 BRONCHOPULMONARY ASPERGILLOSIS 28
701 CATHETER SITE PAIN 28
702 COAGULOPATHY 28
703 COLD SWEAT 28
704 COMA 28
705 DISTURBANCE IN ATTENTION 28
706 ESCHERICHIA SEPSIS 28
707 EXPIRED DEVICE USED 28
708 FAECES DISCOLOURED 28
709 GASTROINTESTINAL INFECTION 28
710 HYPERLEUKOCYTOSIS 28
711 IMMUNODEFICIENCY 28
712 IRRITABLE BOWEL SYNDROME 28
713 JAUNDICE 28
714 MATERNAL EXPOSURE DURING PREGNANCY 28
715 SPLENIC INFARCTION 28
716 THIRST 28
717 TONGUE COATED 28
718 TRANSIENT ISCHAEMIC ATTACK 28
719 WOUND INFECTION 28
720 ANAESTHESIA 27
721 APPLICATION SITE INJURY 27
722 ARTHROPATHY 27
723 ASPIRATION 27
724 ATRIAL FLUTTER 27
725 CATARACT 27
726 DACRYOSTENOSIS ACQUIRED 27
727 ESCHERICHIA URINARY TRACT INFECTION 27
728 HYPOAESTHESIA ORAL 27
729 IMMUNOSUPPRESSION 27
730 LEUKAEMIA 27
731 LIVER ABSCESS 27
732 METASTASES TO SPINE 27
733 NEOPLASM 27
734 ORTHOSTATIC HYPOTENSION 27
735 PANCREATITIS ACUTE 27
736 THERAPEUTIC PRODUCT EFFECT DECREASED 27
737 TOOTH LOSS 27
738 TREATMENT FAILURE 27
739 URINARY TRACT OBSTRUCTION 27
740 BLINDNESS 26
741 FAILURE TO THRIVE 26
742 FIBRIN D DIMER INCREASED 26
743 HAEMATEMESIS 26
744 HYPERURICAEMIA 26
745 INJECTION SITE EXTRAVASATION 26
746 INTERCEPTED PRODUCT STORAGE ERROR 26
747 IRRITABILITY 26
748 LYMPHADENECTOMY 26
749 MUSCLE TIGHTNESS 26
750 ORGANISING PNEUMONIA 26
751 PERIPHERAL COLDNESS 26
752 PROCTALGIA 26
753 PULMONARY HYPERTENSION 26
754 ROAD TRAFFIC ACCIDENT 26
755 SECOND PRIMARY MALIGNANCY 26
756 UNRESPONSIVE TO STIMULI 26
757 ACCIDENTAL UNDERDOSE 25
758 ACNE 25
759 BACTERIAL SEPSIS 25
760 CHOLESTASIS 25
761 CHRONIC KIDNEY DISEASE 25
762 CONJUNCTIVITIS 25
763 DRUG ADMINISTRATION ERROR 25
764 ERYSIPELAS 25
765 ESCHERICHIA BACTERAEMIA 25
766 GROIN PAIN 25
767 HERPES SIMPLEX 25
768 HYPERTHYROIDISM 25
769 ISCHAEMIC STROKE 25
770 ONYCHOMADESIS 25
771 OSTEOPENIA 25
772 OVARIAN CANCER 25
773 SKIN BURNING SENSATION 25
774 TUMOUR PAIN 25
775 VENTRICULAR TACHYCARDIA 25
776 ATYPICAL PNEUMONIA 24
777 BLOOD PRESSURE ABNORMAL 24
778 BLOOD URIC ACID INCREASED 24
779 BRONCHOSPASM 24
780 DIALYSIS 24
781 DIPLOPIA 24
782 EYE IRRITATION 24
783 GENERAL PHYSICAL CONDITION ABNORMAL 24
784 IMMUNE SYSTEM DISORDER 24
785 INTRACRANIAL PRESSURE INCREASED 24
786 METASTASIS 24
787 NASAL MUCOSAL DISORDER 24
788 PHOTOPHOBIA 24
789 PNEUMONIA FUNGAL 24
790 SEROMA 24
791 THERAPEUTIC PROCEDURE 24
792 TOOTH DISORDER 24
793 VENOUS THROMBOSIS 24
794 BLOOD CHLORIDE DECREASED 23
795 BREAST MASS 23
796 CANDIDIASIS 23
797 CARDIOMEGALY 23
798 CATHETER RELATED INFECTION 23
799 DRUG ERUPTION 23
800 ENTEROCOCCAL INFECTION 23
801 FULL BLOOD COUNT ABNORMAL 23
802 HEPATIC LESION 23
803 HYPOVOLAEMIA 23
804 INTERNATIONAL NORMALISED RATIO INCREASED 23
805 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23
806 METASTATIC NEOPLASM 23
807 NAIL BED INFLAMMATION 23
808 NEPHROPATHY TOXIC 23
809 NEUROBLASTOMA RECURRENT 23
810 OESOPHAGEAL CANDIDIASIS 23
811 PERFORMANCE STATUS DECREASED 23
812 PYELONEPHRITIS 23
813 RESPIRATORY RATE INCREASED 23
814 SKIN TOXICITY 23
815 ABDOMINAL RIGIDITY 22
816 B-CELL LYMPHOMA 22
817 CATHETER SITE ERYTHEMA 22
818 CORONARY ARTERY DISEASE 22
819 DENTAL CARIES 22
820 DIVERTICULUM 22
821 ELECTROCARDIOGRAM QT PROLONGED 22
822 EXTRAVASATION 22
823 FEAR OF INJECTION 22
824 INCONTINENCE 22
825 MASTITIS 22
826 NOCTURIA 22
827 PERIPHERAL MOTOR NEUROPATHY 22
828 PROCEDURAL PAIN 22
829 PROSTATE CANCER 22
830 PYODERMA GANGRENOSUM 22
831 SCIATICA 22
832 SINUS DISORDER 22
833 SINUS HEADACHE 22
834 SMALL INTESTINAL PERFORATION 22
835 SUBARACHNOID HAEMORRHAGE 22
836 THERAPY CESSATION 22
837 TROPONIN INCREASED 22
838 WOUND SECRETION 22
839 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 21
840 DRUG EFFECT DECREASED 21
841 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21
842 DRUG TOXICITY 21
843 ENERGY INCREASED 21
844 EXPOSURE VIA SKIN CONTACT 21
845 GINGIVAL BLEEDING 21
846 HEART RATE IRREGULAR 21
847 HYPERLIPIDAEMIA 21
848 HYPERTRANSAMINASAEMIA 21
849 INJECTION SITE MASS 21
850 LACERATION 21
851 LACTIC ACIDOSIS 21
852 METABOLIC DISORDER 21
853 NON-SMALL CELL LUNG CANCER 21
854 PANIC ATTACK 21
855 PHARYNGITIS 21
856 POOR PERIPHERAL CIRCULATION 21
857 RIB FRACTURE 21
858 SKIN IRRITATION 21
859 SNEEZING 21
860 THERAPEUTIC RESPONSE UNEXPECTED 21
861 TOOTH FRACTURE 21
862 ABDOMINAL ABSCESS 20
863 ANAL FISTULA 20
864 CARDIOVASCULAR DISORDER 20
865 CATHETER SITE RELATED REACTION 20
866 CULTURE URINE POSITIVE 20
867 DECREASED ACTIVITY 20
868 EAR DISCOMFORT 20
869 ERUCTATION 20
870 GASTROINTESTINAL INFLAMMATION 20
871 HAEMOLYSIS 20
872 HEPATITIS 20
873 HEPATITIS CHOLESTATIC 20
874 HEPATOMEGALY 20
875 HYPERTRIGLYCERIDAEMIA 20
876 INCREASED APPETITE 20
877 INTERCEPTED DRUG ADMINISTRATION ERROR 20
878 MYOSITIS 20
879 NAIL INFECTION 20
880 ONYCHOCLASIS 20
881 ORAL DISCOMFORT 20
882 PHARYNGEAL ERYTHEMA 20
883 PRURITUS GENERALISED 20
884 PSEUDOMONAL BACTERAEMIA 20
885 RASH PUSTULAR 20
886 ABNORMAL FAECES 19
887 ACUTE CORONARY SYNDROME 19
888 ALTERED STATE OF CONSCIOUSNESS 19
889 ANGIOPATHY 19
890 ANHEDONIA 19
891 ATAXIA 19
892 BLOOD GLUCOSE ABNORMAL 19
893 BLOOD PRESSURE DIASTOLIC DECREASED 19
894 BONE MARROW NECROSIS 19
895 CANCER PAIN 19
896 COVID-19 PNEUMONIA 19
897 DISABILITY 19
898 INTERVERTEBRAL DISC DEGENERATION 19
899 MALIGNANT MELANOMA 19
900 PHOTOSENSITIVITY REACTION 19
901 POLYURIA 19
902 POSTOPERATIVE WOUND INFECTION 19
903 PROTEIN TOTAL DECREASED 19
904 RHEUMATOID ARTHRITIS 19
905 SUICIDAL IDEATION 19
906 TONSILLITIS 19
907 TUMOUR MARKER INCREASED 19
908 VAGINAL DISCHARGE 19
909 VEIN DISORDER 19
910 ACCIDENTAL OVERDOSE 18
911 ALVEOLITIS ALLERGIC 18
912 APPETITE DISORDER 18
913 APPLICATION SITE HAEMATOMA 18
914 CHOLANGITIS 18
915 COLITIS ISCHAEMIC 18
916 COLORECTAL CANCER METASTATIC 18
917 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18
918 DYSKINESIA 18
919 FLUID OVERLOAD 18
920 GOUT 18
921 HIP FRACTURE 18
922 HYPOGAMMAGLOBULINAEMIA 18
923 INJECTION SITE RASH 18
924 JUGULAR VEIN THROMBOSIS 18
925 KLEBSIELLA TEST POSITIVE 18
926 NEOPLASM RECURRENCE 18
927 ORAL INTAKE REDUCED 18
928 PHARYNGOLARYNGEAL PAIN 18
929 PULMONARY ALVEOLAR HAEMORRHAGE 18
930 RHEUMATOID NODULE 18
931 ROSACEA 18
932 STEVENS-JOHNSON SYNDROME 18
933 SUNBURN 18
934 TOOTH EXTRACTION 18
935 APPLICATION SITE WARMTH 17
936 BLEPHARITIS 17
937 BLOOD CREATININE DECREASED 17
938 CATHETER SITE INFECTION 17
939 CHEST X-RAY ABNORMAL 17
940 CRYING 17
941 CYST 17
942 DRUG-INDUCED LIVER INJURY 17
943 EMPHYSEMA 17
944 FOREIGN BODY SENSATION IN EYES 17
945 GINGIVITIS 17
946 HAEMORRHOIDAL HAEMORRHAGE 17
947 HYPOTONIA 17
948 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 17
949 IMPAIRED WORK ABILITY 17
950 JAW DISORDER 17
951 LEFT VENTRICULAR HYPERTROPHY 17
952 MITRAL VALVE DISEASE 17
953 NASAL DRYNESS 17
954 PERIORBITAL OEDEMA 17
955 POLYDIPSIA 17
956 POST PROCEDURAL COMPLICATION 17
957 PURPURA 17
958 RECTAL FISSURE 17
959 SARS-COV-2 TEST POSITIVE 17
960 STENOTROPHOMONAS INFECTION 17
961 T-CELL LYMPHOMA 17
962 TACHYARRHYTHMIA 17
963 TEMPERATURE INTOLERANCE 17
964 TOXIC EPIDERMAL NECROLYSIS 17
965 ALOPECIA TOTALIS 16
966 APHONIA 16
967 APPLICATION SITE VESICLES 16
968 ARTERIOSCLEROSIS 16
969 AXILLARY PAIN 16
970 BLOOD CREATINE PHOSPHOKINASE INCREASED 16
971 BLOOD PRESSURE FLUCTUATION 16
972 CAROTID ARTERY OCCLUSION 16
973 COLON CANCER METASTATIC 16
974 CYANOSIS 16
975 DIARRHOEA HAEMORRHAGIC 16
976 ENTEROCOLITIS INFECTIOUS 16
977 EOSINOPHILIA 16
978 EYE PRURITUS 16
979 FRUSTRATION TOLERANCE DECREASED 16
980 GASTRIC CANCER 16
981 GUILLAIN-BARRE SYNDROME 16
982 IMPETIGO 16
983 LOOSE TOOTH 16
984 LUNG CONSOLIDATION 16
985 METASTASES TO MENINGES 16
986 NODULE 16
987 PNEUMOCYSTIS JIROVECI PNEUMONIA 16
988 PNEUMONIA BACTERIAL 16
989 RESPIRATORY TRACT CONGESTION 16
990 RHINITIS ALLERGIC 16
991 SKIN HYPERPIGMENTATION 16
992 SMALL CELL LUNG CANCER 16
993 SPINAL COMPRESSION FRACTURE 16
994 SUBDURAL HAEMATOMA 16
995 TEARFULNESS 16
996 WALKING AID USER 16
997 ACTINIC KERATOSIS 15
998 ANAL INCONTINENCE 15
999 AORTIC WALL HYPERTROPHY 15